Table 1.
Characteristic | Main Cohort (Total Participants: 50) | Alternate Cohort (Total Participants: 50) | ||
---|---|---|---|---|
BCG-naïve (n = 21) | BCG-vaccinated (n = 29) | BCG-naïve (n = 16) | BCG-vaccinated (n = 34) | |
Female [no. (%)] | 17 (81.0%) | 15 (51.7%) | 11 (68.75%) | 27 (79.4%) |
Median age [yr (range)] |
30 (22–69) |
33 (22–63) |
27.5 (23–53) |
33.5 (25–70) |
Average time since BCG vaccination [yr (range)] |
— | 25.4 (9–52) |
— | 25.9 (10–48) |
Country of Origin UK [no. (%)] | 5 (23.8%) | 20 (69%) | 3 (18.8%) | 24 (70.6%) |